23andMe Lays Off 40 Percent of its Staff, Ends All Therapy Programs
As founder and CEO Anne Wojcicki struggles to take the company private, 200 jobs are cut as part of its restructuring plan.
Read more at Inc.
-
23andMe Lays Off 40% of Staff, Shuts Drug Development Business
Business - The Wall Street Journal - November 11 -
23andMe to slash 40% of its workforce, end therapeutics program to cut costs
Business - MarketWatch - November 12 -
DNA-testing site 23andMe to lay off 40% of its workers
Top stories - BBC News - November 12 -
23andMe to lay off 40% of its workforce as stock price plummets
Top stories - CBS News - November 12 -
23andMe cuts 40% of its workforce and discontinues therapeutics division
Health - ABC News - November 12 -
Genetic testing firm 23andMe cuts 40% of its workforce amid financial struggles
World - The Guardian - November 12 -
Enphase to lay off workers and end some operations in Mexico
Business - MarketWatch - November 8 -
Motion picture academy lays off staff at archive and library amid broader restructuring
Entertainment - Los Angeles Times - October 31 -
AMD will lay off nearly 1,000, or 4% of staff, as AI competition heats up
Tech - VentureBeat - November 13
More from Inc.
-
Excellence Exemplified: Leadership Lessons From the Life of Clifton Wharton Jr., Pioneering Black CEO
Business - Inc. - 39 minutes ago -
How Moonlighting as a Mechanic Helped This Female Founder Scale Her Pet Food Startup
Business - Inc. - 1 hour ago -
17 Inspiring Quotes to Fuel Your Ambition and Ignite Your Success in Business and Life
Business - Inc. - 1 hour ago -
After 43 Years, McDonald’s Just Made a Long-Awaited Announcement
Business - Inc. - 2 hours ago -
People Who Excel at Conversation Always Do This, According to a Psychologist Who’s Worked With Thousands of People
Business - Inc. - 2 hours ago